Abstract: Disclosed are methods, systems and non-transitory computer readable memory for vulnerability detection and management. For instance, a method may include obtain asset information for an organization, wherein the asset information indicates a plurality of assets; obtain a set of grouping rules, wherein the set of grouping rules defines a plurality of groups based on asset attributes; obtain asset data from at least one source, wherein the asset data indicates particular attributes for at least a subset of assets of the plurality of assets; determine at least one specific group for each of the subset of assets; generate a data structure associating each asset of the subset of assets to a first group, thereby grouping the subset of assets into the first group; and perform at least one vulnerability management action using a command that applies to all of the assets, and only the assets, of the first group.

Abstract: Disclosed are methods, systems and non-transitory computer readable memory for vulnerability detection and management. For instance, a method may include obtain asset information for an organization, wherein the asset information indicates a plurality of assets; obtain a set of grouping rules, wherein the set of grouping rules defines a plurality of groups based on asset attributes; obtain asset data from at least one source, wherein the asset data indicates particular attributes for at least a subset of assets of the plurality of assets; determine at least one specific group for each of the subset of assets; generate a data structure associating each asset of the subset of assets to a first group, thereby grouping the subset of assets into the first group; and perform at least one vulnerability management action using a command that applies to all of the assets, and only the assets, of the first group.

Abstract: The present invention relates to constructs and methods used to enhance the attachment and implantation of an embryo. It is shown that modified glycolipids and glycolipid-attachment molecule constructs can be used to modify embryos, or localised to target tissues, to enhance interaction between the embryo and the target tissue, (typically the endometrium). The invention may advantageously be used to enhance implantation of embryos in the uterus, for example, in IVF treatments.